Literature DB >> 22413890

The Recent Infection Testing Algorithm (RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland.

Nj Garrett1, S Lattimore, Vl Gilbart, A Aghaizu, G Mensah, J Tosswill, G Murphy, V Delpech.   

Abstract

OBJECTIVES: In order to estimate HIV incidence among high-risk groups, in January 2009 the Health Protection Agency introduced the Recent Infection Testing Algorithm (RITA) in England and Northern Ireland (E&NI), currently the only regions to inform patients of RITA results. This survey of HIV specialists aimed to investigate the role of RITA in patient management and explore clinicians' views on its role in clinical practice and during partner notification.
METHODS: An online questionnaire was distributed to HIV specialists via the British HIV Association membership email list in February 2011.
RESULTS: Forty-two HIV specialists from 32 HIV centres responded to the survey among 90 centres enrolled in the programme (response rate 36%). Testing for recent infection was considered standard of care by 83% of respondents, 80% felt confident in interpreting results and 92% discussed results with patients, particularly in the context of a possible HIV seroconversion illness (96%) or when deciding when to start antiretroviral therapy (70%). A third (36%) of specialists were initially concerned that RITA results may cause additional anxiety among patients; however, no adverse events were reported. The majority (90%) felt that results could assist with contact tracing by prioritizing patients with likely recent infection. However, only a few centres have currently incorporated RITA into their HIV partner notification protocols.
CONCLUSIONS: RITA has been introduced into clinical practice with no reported patient adverse events. Access to results at centre level should be improved. National guidance regarding use of RITA as a tool for contact tracing is required.
© 2012 British HIV Association.

Entities:  

Mesh:

Year:  2012        PMID: 22413890     DOI: 10.1111/j.1468-1293.2012.00990.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  5 in total

Review 1.  Update on HIV in Western Europe.

Authors:  Fumiyo Nakagawa; Andrew N Phillips; Jens D Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

2.  Effectiveness of a pilot partner notification program for new HIV cases in Barcelona, Spain.

Authors:  Patricia Garcia de Olalla; Ema Molas; María Jesús Barberà; Silvia Martín; Encarnació Arellano; Mercè Gosch; Pilar Saladie; Teresa Carbonell; Hernando Knobel; Elia Diez; Joan A Caylà
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

3.  Integration of a recent infection testing algorithm into HIV surveillance in Ireland: improving HIV knowledge to target prevention.

Authors:  E Robinson; J Moran; K O'Donnell; J Hassan; H Tuite; O Ennis; F Cooney; E Nugent; L Preston; S O'Dea; S Doyle; S Keating; J Connell; C De Gascun; D Igoe
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

4.  Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.

Authors:  Elfriede A Agyemang; Andrea A Kim; Trudy Dobbs; Innocent Zungu; Danielle Payne; Andrew D Maher; Kathryn Curran; Evelyn Kim; Hastings Kwalira; Henry Limula; Amitabh Adhikari; Susie Welty; James Kandulu; Rose Nyirenda; Andrew F Auld; George W Rutherford; Bharat S Parekh
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

5.  HIV incidence estimates by sex and age group in the population aged 15 years or over, Brazil, 1986-2018.

Authors:  Célia Landmann Szwarcwald; Paulo Roberto Borges de Souza Júnior; Ana Roberta Pati Pascom; Ronaldo de Almeida Coelho; Rachel Abrahão Ribeiro; Giseli Nogueira Damacena; Deborah Carvalho Malta; Maria Cristina Pimenta; Gerson Fernandes Mendes Pereira
Journal:  Rev Soc Bras Med Trop       Date:  2022-01-28       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.